# Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM)

> **NCT02570100** · NA · TERMINATED · sponsor: **Centre Oscar Lambret** · enrollment: 56 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Biological collection

## Key facts

- **NCT ID:** NCT02570100
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2017-07
- **Final completion:** 2020-10-06
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** The failures of the culture and immunostaining techniques for ALDH do not allow the main objective of the study to be met.
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570100, "Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02570100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*